GI
TAK icon

GAMCO Investors’s Takeda Pharmaceutical TAK Stock Holding History

GAMCO Investors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-63,485
Closed -$964K – 885
2020
Q1 		$964K Buy
63,485
+180
+0.3% +$3.26K 0.01% 550
2019
Q4 		$1.25M Sell
63,305
-1,557
-2% -$29.8K 0.01% 584
2019
Q3 		$1.12M Buy
64,862
+5,155
+9% +$89.2K 0.01% 583
2019
Q2 		$1.06M Buy
59,707
+165
+0.3% +$3K 0.01% 601
2019
Q1 		$1.21M Buy
+59,542
New +$1.2M 0.01% 550

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

GAMCO Investors's TAK Position: Q2 2020 in Review

GAMCO Investors sold out of Takeda Pharmaceutical (TAK) in Q2 2020, closing a stake of 63,485 shares — an estimated $964K sold.

GAMCO Investors first reported a position in TAK in Q1 2019 and held it in 5 quarters. The position peaked at $1.25M in Q4 2019. 309 funds tracked by Wall St. Rank hold TAK as of Q2 2020.

  • GAMCO Investors reported no remaining Takeda Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • GAMCO Investors sold 63,485 Takeda Pharmaceutical shares in Q2 2020, an estimated $964K.
  • GAMCO Investors first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 5 quarters.
  • GAMCO Investors's Takeda Pharmaceutical position peaked at $1.25M in Q4 2019.
  • 309 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2020.

Based on GAMCO Investors's 13F filing for Q2 2020, filed 13 Aug 2020.